| Income Statement | 2025-07-31 | 2025-04-30 | 2024-07-31 | |
|---|---|---|---|---|
| Revenues | 1,963,083 | 2,417,044 | 2,418,163 | |
| Cost of services | 1,388,821 | 1,598,318 | 1,782,779 | |
| Gross profit | 574,262 | 818,726 | 635,384 | |
| Selling, general and administrative expenses | 888,139 | 917,048 | 1,017,166 | |
| Loss from operations | -313,877 | -98,322 | -381,782 | |
| Other income, net | 104,848 | 199,186 | 91,592 | |
| Loss before income tax | -209,029 | 100,864 | -290,190 | |
| Income tax expense (credit) | 4,779 | 5,511 | 19,004 | |
| Net loss | -204,250 | 95,353 | -309,194 | |
| Basic and diluted loss per common share | 0.009 | 0.004 | - | |
| Weighted average number of common shares outstanding - basic | 22,927,283 | 22,934,385 | 22,961,534 | |
| Weighted average number of common shares outstanding - diluted | 22,937,921 | 22,944,408 | 22,961,534 | |
Pharma-Bio Serv, Inc. (PBSV)
Pharma-Bio Serv, Inc. (PBSV)